United States
US 12,697,343 B2
Intravenous istaroxime for the treatment of acute heart failure
US 12,697,343 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Seismic Pharmaceuticals Operations LLC. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Seismic Pharmaceuticals Operations LLC
- Inventors
- Giuseppe Bianchi; Patrizia Ferrari; Mara Ferrandi; Paolo Barassi
- Publication date
- 2026-08-04
- Filing date
- 2023-07-19
- Document type
- B2 Granted patent
- Also written as
- US 12,697,343 B2 · US12697343 · 12697343
Abstract
Described herein are methods of treating acute heart failure in a subject in need thereof, comprising administering a therapeutically effective amount of istaroxime by intravenous infusion over a period of at least 24 hours wherein the therapeutically effective amount of istaroxime is between about 0.1 μg/kg/min and about 3.0 g/kg/min; and wherein the subject's acute heart failure is treated.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free